Teva Pharmaceutical Industries Becomes Oversold (TEVA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of Teva Pharmaceutical Industries Ltd ( TEVA) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $37.55 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 48.3. A bullish investor could look at TEVA's 29.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of TEVA shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Teva Pharmaceutical Industries Ltd 1 Year Performance Chart

Looking at the chart above, TEVA's low point in its 52 week range is $36.63 per share, with $46.38 as the 52 week high point — that compares with a last trade of $37.74.

According to the ETF Finder at ETF Channel, TEVA makes up 4.05% of the Pharmaceutical ETF ( PPH) which is trading relatively unchanged on the day Monday.

null

More from Stocks

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

It's Clear Nvidia Is Leading the A.I. Revolution

It's Clear Nvidia Is Leading the A.I. Revolution

Multiple Tailwinds Take Shape That Could Drive BP Gains

Multiple Tailwinds Take Shape That Could Drive BP Gains

Overwhelmed? Jim Cramer Breaks Down What You Must Watch This Week

Overwhelmed? Jim Cramer Breaks Down What You Must Watch This Week

Why Citron Is Wrong on Tesla

Why Citron Is Wrong on Tesla